Cargando…

Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis

Metal toxicity has been identified as a possible risk factor for amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. We conducted a retrospective chart review of urinary, hair and blood metal levels and serum ferritin in 321 people with ALS seen over a ten-year period at the M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qureshi, Muddasir, Brown Jr, Robert H, Rogers, Jack T, Cudkowicz, Merit E
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627516/ https://www.ncbi.nlm.nih.gov/pubmed/19452011 http://dx.doi.org/10.2174/1874205X00802010051

Ejemplares similares

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
por: Weisskopf, Marc G., et al.
Publicado: (2015)

Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
por: Paydarnia, Parastou, et al.
Publicado: (2021)

Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis
por: Nadjar, Yann, et al.
Publicado: (2012)

Meta-analysis of the relationship between amyotrophic lateral sclerosis and susceptibility to serum ferritin level elevation
por: Hu, Xiaohui, et al.
Publicado: (2016)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis
por: Nicholson, Katharine, et al.
Publicado: (2018)

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
por: Paganoni, Sabrina, et al.
Publicado: (2022)

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
por: Alshikho, Mohamad J., et al.
Publicado: (2016)

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis
por: Garcia‐Montojo, Marta, et al.
Publicado: (2022)

IL6 receptor(358)Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
por: Wosiski-Kuhn, Marlena, et al.
Publicado: (2019)

Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery
por: Gwinn, Katrina, et al.
Publicado: (2007)

Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
por: Wong, Jamie K, et al.
Publicado: (2022)

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach
por: Kueffner, Robert, et al.
Publicado: (2019)

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design
por: Berry, James, et al.
Publicado: (2021)

Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [(11)C]-PBR28
por: Zürcher, Nicole R., et al.
Publicado: (2015)

Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort
por: Peters, Susan, et al.
Publicado: (2020)

Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis
por: Iłżecka, Joanna
Publicado: (2011)

Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis
por: Oh, Seong-il, et al.
Publicado: (2015)

Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015)

Early life metal dysregulation in amyotrophic lateral sclerosis
por: Figueroa‐Romero, Claudia, et al.
Publicado: (2020)

Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
por: Berry, James D., et al.
Publicado: (2013)

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis
por: Salter, Matthew, et al.
Publicado: (2018)

Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis
por: Liu, Juan, et al.
Publicado: (2015)

Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis
por: Guo, Qi‐Fu, et al.
Publicado: (2021)

Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
por: Ikenaka, Kensuke, et al.
Publicado: (2022)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2022)

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
por: Babu, Suma, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
por: Thonhoff, Jason R., et al.
Publicado: (2022)

Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)

A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
por: Cudkowicz, Merit E., et al.
Publicado: (2022)

Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses
por: Miller, Robert G., et al.
Publicado: (2022)

Serum Uric Acid Levels Predict Mortality Risk in Male Amyotrophic Lateral Sclerosis Patients
por: Xu, Liu-Qing, et al.
Publicado: (2021)

The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
por: Lovejoy, David B., et al.
Publicado: (2014)

Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review
por: Sheykhansari, Sahar, et al.
Publicado: (2018)

Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis
por: Zhang, Fan, et al.
Publicado: (2018)

Risk factors for amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2mjal0mo35atrnd3mqadvs5t9j